The views and opinions expressed are those of the contributing authors and editors and do not necessarily represent the views of the ACC. More
The Cardiac Biomarkers Clinical Community is inviting submissions from the cardiovascular community for new original content.
Dr. Michael Kontos and Dr. Benjamin Scirica discuss GDF-15 in cardiovascular disease.
What would be your next step for this 52-year-old male after his CV risk assessment?
Article from the journal Clinical Chemistry now available.
Dr. Mike Kontos reviews the role of serial changes, and the diagnostic performance of a hsTnI assay compared with a contemporary cTnI.
An exploratory review of the superiority of MR-proANP vs. BNP and NT–pro BNP for diagnosing CHF.
Comparative Value of Coronary Artery Calcium and Multiple Blood Biomarkers for Prognostication of Cardiovascular Events
2-Hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain Symptoms Using Contemporary Troponins as the Only Biomarker: The ADAPT Trial
Plasma PCSK9 Levels and Clinical Outcomes in the TNT (Treating to New Targets) Trial: A Nested Case-Control Study
